Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
21 hedge funds and large institutions have $415K invested in Biotricity, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
5% less funds holding
Funds holding: 22 → 21 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
61% less capital invested
Capital invested by funds: $1.08M → $415K (-$662K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$28.9K |
| 2 |
HF
HRT Financial
New York
|
+$25K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$337 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$132 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$193K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63.8K |
| 3 |
OSNBOA
Old Second National Bank of Aurora
Aurora,
Illinois
|
-$5.35K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.03K |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$2.67K |
BTCY Hedge Fund Activity: Q4 2023 in Review
21 of the 6,868 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q4 2023, worth a combined $415K — down 61% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BTCY and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $28.9K. The largest seller was Vanguard Group, cutting an estimated $193K.
- 21 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q4 2023, down from 22 in Q3 2023.
- Funds reported $415K of Biotricity, Inc. Common Stock stock for Q4 2023, down 61% quarter-over-quarter.
- 3 funds opened new Biotricity, Inc. Common Stock positions in Q4 2023 and 4 closed out, a net change of -1 holder.
- The largest Biotricity, Inc. Common Stock buyer in Q4 2023 was Citadel Advisors, an estimated $28.9K added.
- The largest Biotricity, Inc. Common Stock seller in Q4 2023 was Vanguard Group, an estimated $193K sold.
Based on aggregated 13F filings for Q4 2023.